TY - JOUR
T1 - Direct-MS analysis of antibody-antigen complexes
AU - Vimer, Shay
AU - Ben-Nissan, Gili
AU - Marty, Michael
AU - Fleishman, Sarel J.
AU - Sharon, Michal
N1 - Funding Information:
M.S. is grateful for the support of an Israel Science Foundation grant (300/17). M.S. is the incumbent of the Aharon and Ephraim Katzir Memorial Professorial Chair. S.J.F.’s research is supported by a charitable donation in memory of Sam Switzer and the Dr. Barry Sherman Institute of Medicinal Chemistry. The research of S.V. is supported by the Clore Israel Foundation. M.T.M was supported by the National Institutes of Health/National Institute of General Medical Sciences (R35 GM128624). We thank R. Rogawski for valuable comments on this manuscript.
Publisher Copyright:
© 2021 Wiley-VCH GmbH.
PY - 2021/11
Y1 - 2021/11
N2 - In recent decades, antibodies (Abs) have attracted the attention of academia and the biopharmaceutical industry due to their therapeutic properties and versatility in binding a vast spectrum of antigens. Different engineering strategies have been developed for optimizing Ab specificity, efficacy, affinity, stability and production, enabling systematic screening and analysis procedures for selecting lead candidates. This quality assessment is critical but usually demands time-consuming and labor-intensive purification procedures. Here, we harnessed the direct-mass spectrometry (direct-MS) approach, in which the analysis is carried out directly from the crude growth media, for the rapid, structural characterization of designed Abs. We demonstrate that properties such as stability, specificity and interactions with antigens can be defined, without the need for prior purification.
AB - In recent decades, antibodies (Abs) have attracted the attention of academia and the biopharmaceutical industry due to their therapeutic properties and versatility in binding a vast spectrum of antigens. Different engineering strategies have been developed for optimizing Ab specificity, efficacy, affinity, stability and production, enabling systematic screening and analysis procedures for selecting lead candidates. This quality assessment is critical but usually demands time-consuming and labor-intensive purification procedures. Here, we harnessed the direct-mass spectrometry (direct-MS) approach, in which the analysis is carried out directly from the crude growth media, for the rapid, structural characterization of designed Abs. We demonstrate that properties such as stability, specificity and interactions with antigens can be defined, without the need for prior purification.
KW - antibody antigen interactions
KW - antibody deign
KW - native mass spectrometry
KW - protein stability
UR - http://www.scopus.com/inward/record.url?scp=85112630058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112630058&partnerID=8YFLogxK
U2 - 10.1002/pmic.202000300
DO - 10.1002/pmic.202000300
M3 - Article
C2 - 34310051
AN - SCOPUS:85112630058
VL - 21
JO - Proteomics
JF - Proteomics
SN - 1615-9853
IS - 21-22
M1 - 2000300
ER -